Delivery of subunit vaccines in maize seed

The use of recombinant gene technologies by the vaccine industry has revolutionized the way antigens are generated, and has provided safer, more effective means of protecting animals and humans against bacterial and viral pathogens. Viral and bacterial antigens for recombinant subunit vaccines have...

Full description

Saved in:
Bibliographic Details
Published inJournal of controlled release Vol. 85; no. 1; pp. 169 - 180
Main Authors Lamphear, Barry J, Streatfield, Stephen J, Jilka, Joseph M, Brooks, Christopher A, Barker, Donna K, Turner, Debra D, Delaney, Donna E, Garcia, Martin, Wiggins, Barry, Woodard, Susan L, Hood, Elizabeth E, Tizard, Ian R, Lawhorn, Bruce, Howard, John A
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 13.12.2002
Elsevier Science B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The use of recombinant gene technologies by the vaccine industry has revolutionized the way antigens are generated, and has provided safer, more effective means of protecting animals and humans against bacterial and viral pathogens. Viral and bacterial antigens for recombinant subunit vaccines have been produced in a variety of organisms. Transgenic plants are now recognized as legitimate sources for these proteins, especially in the developing area of oral vaccines, because antigens have been shown to be correctly processed in plants into forms that elicit immune responses when fed to animals or humans. Antigens expressed in maize ( Zea mays) are particularly attractive since they can be deposited in the natural storage vessel, the corn seed, and can be conveniently delivered to any organism that consumes grain. We have previously demonstrated high level expression of the B-subunit of Escherichia coli heat-labile enterotoxin and the spike protein of swine transmissible gastroenteritis in corn, and have demonstrated that these antigens delivered in the seed elicit protective immune responses. Here we provide additional data to support the potency, efficacy, and stability of recombinant subunit vaccines delivered in maize seed.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0168-3659
1873-4995
DOI:10.1016/S0168-3659(02)00282-1